Quantbot Technologies’s Rocket Pharmaceuticals RCKT Stock Holding History

Quantbot Technologies’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-331	Closed	-$1.19K	–	2193
2026 Q1	$1.19K	Buy	+331	New	+$1.32K	﹤0.01%	1622
2023 Q4	–	Sell	-1,000	Closed	-$20.5K	–	1914
2023 Q3	$20.5K	Buy	+1,000	New	+$18.2K	﹤0.01%	1349
2022 Q4	–	Sell	-19,657	Closed	-$313K	–	2035
2022 Q3	$313K	Sell	19,657 -3,592	-15%	-$56K	0.02%	736
2022 Q2	$319K	Buy	+23,249	New	+$277K	0.03%	752
2021 Q3	–	Sell	-300	Closed	-$13K	–	1821
2021 Q2	$13K	Sell	300 -2,560	-90%	-$111K	﹤0.01%	1282
2021 Q1	$126K	Buy	2,860 +2,160	+309%	+$119K	0.01%	831
2020 Q4	$38K	Buy	+700	New	+$25.5K	﹤0.01%	908
2019 Q3	–	Sell	-700	Closed	-$10K	–	1514
2019 Q2	$10K	Buy	+700	New	+$12.2K	﹤0.01%	1091
2018 Q2	–	Sell	-248	Closed	-$4K	–	1438
2018 Q1	$4K	Buy	+248	New	+$4.04K	﹤0.01%	1142

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Quantbot Technologies's RCKT Position: Q2 2026 in Review

Quantbot Technologies sold out of Rocket Pharmaceuticals (RCKT) in Q2 2026, closing a stake of 331 shares — an estimated $1.19K sold.

Quantbot Technologies first reported a position in RCKT in Q1 2018 and held it in 9 quarters. The position peaked at $319K in Q2 2022. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

Quantbot Technologies reported no remaining Rocket Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Quantbot Technologies sold 331 Rocket Pharmaceuticals shares in Q2 2026, an estimated $1.19K.
Quantbot Technologies first reported a position in Rocket Pharmaceuticals in Q1 2018 and held it in 9 quarters.
Quantbot Technologies's Rocket Pharmaceuticals position peaked at $319K in Q2 2022.
180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.